Page last updated: 2024-08-17

medroxyprogesterone acetate and Bone Cancer

medroxyprogesterone acetate has been researched along with Bone Cancer in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	14 (30.43)	18.7374
1990's	16 (34.78)	18.2507
2000's	14 (30.43)	29.6817
2010's	1 (2.17)	24.3611
2020's	1 (2.17)	2.80

Authors

Authors	Studies
Bunce, CM; Ellington, MA; Johnson, WE; Khanim, FL; MacKay, HL; Sheard, JJ; Snow, MD; Southam, AD	1
Kusama, M	1
Chen, Y; Rittling, SR	1
Suda, T	1
Arima, T; Horino, K; Inoue, M; Kaneda, H; Kimura, M; Kuhara, H; Kume, S; Nakano, M; Nishimura, T; Uemura, K	1
Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H	1
Kurebayashi, J	1
Beaufort, F; Gölles, M	1
Carlino, F; Fiorentini, L; Mariani, G; Minervini, R	1
Ausilli-Cefaro, GP; Minotti, G; Saccheri, S; Trodella, L; Turriziani, A; Venturo, I	1
Beaufort, F; Fereberger, W	1
Canigiula, L; Riundi, R; Scanni, A; Vezzoni, MA	1
Belnome, N; Calbo, L; Di Mauro, S; Melita, P; Navarra, S	1
Aitini, E; Bajetta, E; Biganzoli, L; Bochicchio, AM; Buzzoni, R; Comella, G; D'Aprile, M; Di Leo, A; Nolè, F; Veltri, E	1
Jiang, Z; Li, J; Song, S	1
Kiyono, T; Kurebayashi, J; Ohta, K; Shimozuma, K; Sonoo, H	1
Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T	1
Atkins, JN; Bearden, JD; Case, LD; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; O'Rourke, MA; Pavy, MD; Powell, BL	1
Andoh, T; Iijima, T; Iino, Y; Inoue, T; Izumi, M; Kobayashi, I; Morishita, Y; Yamada, T; Yokoe, T; Yokota, T	1
Ansai, Y; Fujimaki, M; Hino, K; Karaki, Y; Shimada, K; Yamashita, Y	1
Baba, K; Fukuda, M; Higuchi, A; Ikeda, K; Matsuda, M; Matsuoka, Y; Nagao, K; Nishimura, R; Yamashita, H	1
Fujii, T; Kanno, K; Ogata, T; Roppongi, T; Yokota, T	1
Higashi, Y; Iino, Y; Ishiguro, S; Kurihara, T; Morishita, Y; Suemasu, K; Tabei, T; Takeda, F	1
Kihara, M; Maeda, M; Matsusaka, K; Miyauchi, A	1
Kokawa, Y; Naito, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G	1
Katagata, N; Matsuoka, T; Nomizu, T; Takenoshita, S; Tsuchiya, A; Watanabe, F; Yabuta, T; Yamaki, Y	1
Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T	1
Anan, K; Mitsuyama, S	1
Fujii, M; Kaiga, T; Ueda, T; Watanabe, Y	1
Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Nakayama, S; Oota, D; Shimizu, H	1
Aihara, N; Fukunaga, M; Iba, T; Kidokoro, A; Suda, M; Sugiyama, K	1
Imatomi, M; Miyamoto, H; Nakata, A; Saitoh, T; Yoshida, S	1
Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Matunaga, T; Misaka, T; Nakayama, S; Ota, D	1
Sasagawa, I; Satomi, S	1
Clavel, M	1
Andersson, SO; Holmberg, L; Johansson, JE	1
Kawahara, T; Kobayakawa, K; Okamura, Y; Takatsuka, Y; Tsumura, I	1
Bezwoda, WR	1
Katayama, T; Sasagawa, I; Satomi, S	1
Becher, R; Gerhold, U; Hirche, H; Höffken, K; Miller, AA; Schmidt, CG	1
Inaii, H; Koyama, H; Noguchi, S; Yamamoto, H	1
Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G	1
Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE	1
Blackledge, GR; Latief, T; Morrison, M; Mould, JJ; Spooner, D	1
Baroni, M; Longhi, A; Martoni, A; Pannuti, F; Piana, E	1
Amin, R	1

Reviews

4 review(s) available for medroxyprogesterone acetate and Bone Cancer

Article	Year
[Bone-related events in breast cancer]. Clinical calcium, 2008, Volume: 18, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Medroxyprogesterone Acetate; Osteolysis; Parathyroid Hormone-Related Protein; RANK Ligand; Transforming Growth Factor beta	2008
[Systemic therapy, pain relief and quality of life of breast cancer patients with bone metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Morphine; Pain, Intractable; Quality of Life; Tamoxifen	1995
[Medroxyprogesterone acetate for treatment of advanced breast cancers]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58 Suppl Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Medroxyprogesterone Acetate; Quality of Life; Thrombosis	2000
Management of breast cancer with bone metastases. Bone, 1991, Volume: 12 Suppl 1 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Estrogens; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Palliative Care; Survival Rate	1991

Trials

9 trial(s) available for medroxyprogesterone acetate and Bone Cancer

Article	Year
[Calcitonin in bone-metastasizing breast carcinoma. Results of a pilot study]. Onkologie, 1984, Volume: 7, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Pain, Intractable; Palliative Care; Pilot Projects	1984
Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group. American journal of clinical oncology, 1995, Volume: 18, Issue:3 Topics: Aged; Ambulatory Care; Bone Neoplasms; Drug Synergism; Drug Therapy, Combination; Epirubicin; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Survival Analysis	1995
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Soft Tissue Neoplasms	1995
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Regression Analysis; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen	1994
Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Forecasting; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen; Soft Tissue Neoplasms; Treatment Outcome	1997
[The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7 Topics: Adult; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Quality of Life	2001
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study. British journal of urology, 1991, Volume: 68, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Delayed-Action Preparations; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Prostatic Neoplasms; Time Factors	1991
Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens. Comparison of aminoglutethimide plus hydrocortisone with medroxyprogesterone acetate plus hydrocortisone. British journal of urology, 1990, Volume: 66, Issue:2 Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Diethylstilbestrol; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Staging; Orchiectomy; Postoperative Period; Prostatic Neoplasms; Randomized Controlled Trials as Topic	1990
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological The Journal of urology, 1986, Volume: 136, Issue:3 Topics: Aged; Bone Neoplasms; Carcinoma; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation	1986

Other Studies

33 other study(ies) available for medroxyprogesterone acetate and Bone Cancer

Article	Year
Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells. Bioscience reports, 2021, 01-29, Volume: 41, Issue:1 Topics: Bezafibrate; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Repositioning; Drug Therapy, Combination; Fatty Acid Synthases; Humans; Medroxyprogesterone Acetate; Mesenchymal Stem Cells; Osteosarcoma; Stearoyl-CoA Desaturase; Up-Regulation; Valproic Acid	2021
[Doxifluridine, medroxyprogesterone acetate and cyclophosphamide(DMpC)combination therapy found effective for case of chest wall recurrent breast cancer with bone and pleural metastases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Pleural Neoplasms; Quality of Life; Recurrence; Thoracic Wall	2012
Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing. Clinical & experimental metastasis, 2003, Volume: 20, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antigens, Polyomavirus Transforming; Antineoplastic Agents, Hormonal; Bone Neoplasms; Carcinogens; Cell Transformation, Neoplastic; Epithelial Cells; Female; Genes, ras; Heart Ventricles; Humans; Keratins; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Neoplastic Cells, Circulating; Osteolysis; Osteopontin; Retroviridae; Sialoglycoproteins; Transfection; Tumor Cells, Cultured	2003
[Effective reduction of elevated tumor markers by exemestane--a 12-year follow-up of a case of bone metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:3 Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Mucin-1; Radionuclide Imaging	2005
[A case of recurrent breast cancer with bone metastasis causing pancytopenia--efficacy of low-dose CPT-11+ MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Camptothecin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Irinotecan; Mastectomy, Segmental; Medroxyprogesterone Acetate; Middle Aged; Pancytopenia; Quality of Life	2005
[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5 Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged	2005
Regression of skeletal metastases from hypernephroma following long-term treatment with medroxyprogesterone acetate. The Journal of urology, 1982, Volume: 128, Issue:3 Topics: Adenocarcinoma; Bone Neoplasms; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1982
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Skin Neoplasms; Tamoxifen	1982
[High-dose gestagen therapy in breast cancer]. Wiener medizinische Wochenschrift (1946), 1983, Apr-15, Volume: 133, Issue:7 Topics: Adult; Bone Neoplasms; Breast Neoplasms; Castration; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk; Soft Tissue Neoplasms	1983
Calcification of humeral metastasis of renal adenocarcinoma 8 months after medroxyprogesterone acetate therapy. The Journal of urology, 1984, Volume: 131, Issue:5 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Female; Humans; Humerus; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate	1984
[Hormone treatment of metastasizing breast carcinoma]. Minerva chirurgica, 1981, Jun-30, Volume: 36, Issue:12 Topics: Bone Neoplasms; Breast Neoplasms; Castration; Estradiol Congeners; Humans; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Progesterone Congeners; Tamoxifen; Testosterone Congeners	1981
[Clinical trial of high-dose medroxyprogesterone acetate in advanced breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:1 Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local	1995
[Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Mitoxantrone	1994
[A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:5 Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Pleural Neoplasms; Remission Induction	1996
[A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged	1998
Multidrug-resistant recurrent breast cancer which responded to medroxyprogesterone acetate showing a remarkable improvement in the quality of life: report of a case and the role of team medical care. Surgery today, 1998, Volume: 28, Issue:9 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Palliative Care; Patient Care Team; Quality of Life	1998
[A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Floxuridine; Humans; Lymphatic Metastasis; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction	1998
[Pain relief with alendronate therapy in a breast cancer patient with bone metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:4 Topics: Aged; Alendronate; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Pain; Sternum	2000
[Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Vincristine	2000
[A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pamidronate	2000
[A case of advanced breast cancer that responded remarkably to chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged	2000
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:14 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Tamoxifen; Tegafur; Uracil	2000
[Successful treatment of advanced recurent breast cancer using DMpC therapy as maintenance therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local	2002
[A case of breast cancer with multiple bone metastases that responded remarkably to doxifluridine (5'-DFUR), cyclophosphamide (CPA), medroxyprogesterone acetate (MPA) and pamidronate disodium therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pamidronate; Quality of Life	2002
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer. British journal of urology, 1990, Volume: 65, Issue:3 Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropins; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Prolactin; Prostatic Neoplasms; Thyrotropin	1990
[A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 1 Topics: Adenocarcinoma; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Estrogen; Remission Induction	1990
[Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma]. Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:6 Topics: Adrenocorticotropic Hormone; Back Pain; Bone and Bones; Bone Neoplasms; Chlormadinone Acetate; Dehydroepiandrosterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging	1989
High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen. Cancer, 1989, May-15, Volume: 63, Issue:10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged	1989
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Remission Induction; Soft Tissue Neoplasms; Tamoxifen; Weight Gain	1989
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO). Cancer, 1986, Nov-01, Volume: 58, Issue:9 Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Pain	1986
Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged	1986
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Remission Induction	1987
Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy. Urology, 1988, Volume: 32, Issue:3 Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Renal Artery	1988